BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-21 Cr | ₹-15 Cr | ₹-7.49 Cr | ₹-6.54 Cr | ₹-5.35 Cr |
What is the latest Cash Flow from Investing Activities ratio of BAFNA PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-21 Cr |
| Mar2024 | ₹-15 Cr |
| Mar2023 | ₹-7.49 Cr |
| Mar2022 | ₹-6.54 Cr |
| Mar2021 | ₹-5.35 Cr |
How is Cash Flow from Investing Activities of BAFNA PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-21 Cr | Negative | |
| Mar2024 | ₹-15 Cr | Negative | |
| Mar2023 | ₹-7.49 Cr | Negative | |
| Mar2022 | ₹-6.54 Cr | Negative | |
| Mar2021 | ₹-5.35 Cr | - | |
Compare Cash Flow from Investing Activities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹511.7 Cr | 4% | 29.9% | 182.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 4% |
29.9% |
182.3% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses